Title |
The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand
|
---|---|
Published in |
Applied Health Economics and Health Policy, July 2014
|
DOI | 10.1007/s40258-014-0110-0 |
Pubmed ID | |
Authors |
Charon Lessing, Toni Ashton, Peter Davis |
Abstract |
Many countries have implemented generic reference pricing and substitution as methods of containing pharmaceutical expenditure. However, resistance to switching between medicines is apparent, especially in the case of anti-epileptic medicines. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
New Zealand | 1 | 25% |
Unknown | 3 | 75% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ethiopia | 1 | 2% |
Unknown | 42 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 19% |
Student > Master | 7 | 16% |
Student > Ph. D. Student | 6 | 14% |
Other | 5 | 12% |
Student > Doctoral Student | 2 | 5% |
Other | 6 | 14% |
Unknown | 9 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 26% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 16% |
Social Sciences | 4 | 9% |
Business, Management and Accounting | 2 | 5% |
Agricultural and Biological Sciences | 2 | 5% |
Other | 6 | 14% |
Unknown | 11 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2019.
All research outputs
#13,410,148
of 22,758,248 outputs
Outputs from Applied Health Economics and Health Policy
#444
of 771 outputs
Outputs of similar age
#108,791
of 225,950 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#9
of 22 outputs
Altmetric has tracked 22,758,248 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 771 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.